Artículo
Antigenic and immunogenic spectrum of foot and mouth disease vaccine strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade
Galdo Novo, Sabrina; Malirat, Viviana
; Maradei, Eduardo D.; Espinoza, Ana María; Smitsaart, Eliana; Pedemonte, Andrea; Mattion, Nora Marta
; Bergmann, Ingrid Evelyn



Fecha de publicación:
04/2017
Editorial:
Elsevier
Revista:
Vaccine
ISSN:
0264-410X
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Identifying vaccine strains to control outbreaks of foot-and-mouth disease virus that could spread to new regions is essential for contingency plans. This is the first report on the antigenic/immunogenic relationships of the South American O1/Campos vaccine strain with representative isolates of the three currently active Asian type O topotypes. Virus neutralization tests using O1/Campos post-vaccination sera derived from cattle and pigs predicted for both species acceptable cross-protection, even after single vaccination, established by r1 values and by expectancy of protection using monovalent or polyvalent vaccines. The results indicate that effective oil vaccines containing the O1/Campos strain can be used against Asian isolates, expanding the scope of O1/Campos strain included in vaccine banks to control emergencies caused by Asian viruses, even on single-dose vaccination, and to cover the need of effective vaccines in Asia during systematic vaccination.
Palabras clave:
Foot-And-Mouth Disease
,
Vaccine Matching
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(ICT - MILSTEIN)
Articulos de INST.DE CS. Y TECNOLOGIA "DR. CESAR MILSTEIN"
Articulos de INST.DE CS. Y TECNOLOGIA "DR. CESAR MILSTEIN"
Citación
Galdo Novo, Sabrina; Malirat, Viviana; Maradei, Eduardo D.; Espinoza, Ana María; Smitsaart, Eliana; et al.; Antigenic and immunogenic spectrum of foot and mouth disease vaccine strain O1 Campos against representative viruses of topotypes that circulated in Asia over the past decade; Elsevier; Vaccine; 35; 18; 4-2017; 2303-2307
Compartir
Altmétricas